title: BCR-ABL mediated repression of miR-223 results in the activation of MEF2C and PTBP2 in chronic myeloid leukemia.
authors.forename: S
authors.initials: S
authors.lastname: Agatheeswaran
authors.forename: S
authors.initials: S
authors.lastname: Singh
authors.forename: S
authors.initials: S
authors.lastname: Biswas
authors.forename: G
authors.initials: G
authors.lastname: Biswas
authors.forename: N
authors.initials: N
authors.lastname: Chandra Pattnayak
authors.forename: S
authors.initials: S
authors.lastname: Chakraborty
mesh_terms: D016044:Fusion Proteins, bcr-abl / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D020014:K562 Cells; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics* / Q000378:metabolism; D026161:MADS Domain Proteins / Q000235:genetics* / Q000378:metabolism; D064326:MEF2 Transcription Factors; D035683:MicroRNAs / Q000235:genetics* / Q000378:metabolism; D018006:Myogenic Regulatory Factors / Q000235:genetics* / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000235:genetics* / Q000378:metabolism; D038941:Polypyrimidine Tract-Binding Protein / Q000235:genetics* / Q000378:metabolism
chemical_list: D016044:Fusion Proteins, bcr-abl; D026161:MADS Domain Proteins; D064326:MEF2 Transcription Factors; D035683:MicroRNAs; D018006:Myogenic Regulatory Factors; D009419:Nerve Tissue Proteins; D038941:Polypyrimidine Tract-Binding Protein; C578040:MEF2C protein, human; C525067:MIR223, human; C504334:PTBP2 protein, human